These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19226966)

  • 1. Effect of epsilon-aminocaproyl-S-benzyl-L-cysteine on the activity of plasminogen activators.
    Bruzgo I; Midura-Nowaczek K; Kaczyńska J; Krajewska D
    Acta Pol Pharm; 2009; 66(1):37-40. PubMed ID: 19226966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of epsilon-aminocaproiloaminoacids on the amidolytic activity of tissue plasminogen activator, urokinase and kallikrein.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Markowska A
    Acta Pol Pharm; 2004; 61(1):75-6. PubMed ID: 15259861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ε-aminocaproyl-S-benzyl-L-cysteine on the t-PA activity of human saliva.
    Midura-Nowaczek K; Kaczyńska J; Bruzgo I; Markowska A; Drozdowska D
    Adv Med Sci; 2011; 56(2):323-6. PubMed ID: 22037173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro simulation of thrombolysis inhibition.
    Stief TW
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):234-7. PubMed ID: 18160584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and activity of dipeptides containing epsilon-aminocaproic acid.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1994; 51(6):499-504. PubMed ID: 7762400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activation at low temperatures in plasma samples containing therapeutic concentrations of tissue-type plasminogen activator or other thrombolytic agents.
    Rijken DC; Seifried E; Barrett-Bergshoeff MM; Dooijewaard G
    Thromb Haemost; 1990 Aug; 64(1):47-52. PubMed ID: 2125758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.
    Gurewich V; Pannell R
    Thromb Haemost; 1987 Jun; 57(3):372-3. PubMed ID: 3116707
    [No Abstract]   [Full Text] [Related]  

  • 8. Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid.
    Niego B; Horvath A; Coughlin PB; Pugsley MK; Medcalf RL
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):322-4. PubMed ID: 18469556
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of some epsilon-aminocaproic acid derivatives on platelet responses.
    Bruzgo I; Tomasiak M; Stelmach H; Midura-Nowaczek K
    Acta Biochim Pol; 2004; 51(1):73-80. PubMed ID: 15094827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. trans-4-(Aminomethyl)cyclohexane carboxylic acid methylamide (t-AMCHA methylamide) inhibits the physical interaction between urokinase-type plasminogen activator and stratum corneum, and accelerates the recovery of barrier function.
    Katsuta Y; Yoshida Y; Kawai E; Suetsugu M; Kohno Y; Inomata S; Kitamura K
    J Dermatol Sci; 2005 Dec; 40(3):218-20. PubMed ID: 16289989
    [No Abstract]   [Full Text] [Related]  

  • 12. Antifibrinolytic activity of epsilon-aminocaproyl derivatives of amino acids.
    Midura-Nowaczek K; Bruzgo I; Dubis E; Roszkowska-Jakimiec W; Worowski K
    Pharmazie; 1996 Oct; 51(10):775-7. PubMed ID: 8941949
    [No Abstract]   [Full Text] [Related]  

  • 13. [Behavior of postoperative adhesions after intraperitoneal administration of fibrinolytic drugs in a rat model].
    Stapel A; Geissler N; Mlasowsky B; Jung D
    Langenbecks Arch Chir; 1997; 382(1):33-6. PubMed ID: 9157230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tranexamic acid, cis-AMCHA, and 6-aminohexanoic acid on the activation rate of plasminogen by urokinase in the presence of clot.
    Takada A; Ohashi H; Matsuda H; Takada Y
    Thromb Res; 1979; 14(6):915-23. PubMed ID: 473126
    [No Abstract]   [Full Text] [Related]  

  • 15. The effective concentration of epsilon-aminocaproic Acid for inhibition of fibrinolysis in neonatal plasma in vitro.
    Yurka HG; Wissler RN; Zanghi CN; Liu X; Tu X; Eaton MP;
    Anesth Analg; 2010 Jul; 111(1):180-4. PubMed ID: 20519417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombolytic agents: efficacy in relation to evolution time and dose].
    García Frade LJ; Torrado MC; Loren M; Navarro JL
    Rev Clin Esp; 1989 Feb; 184(2):75-9. PubMed ID: 2502822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
    Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
    Longstaff C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):537-42. PubMed ID: 7531000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of epsilon-aminocaproylamino acids on fibrin formation.
    Bruzgo I; Midura-Nowaczek K; Bruzgo M; Kaczyńska J; Roszkowska-Jakimiec W
    Acta Pol Pharm; 2006; 63(2):149-52. PubMed ID: 17514879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of platelets on plasminogen activation by tissue plasminogen activator, urokinase, and streptokinase.
    Gao SW; Morser J; McLean K; Shuman MA
    Thromb Res; 1990 May; 58(4):421-33. PubMed ID: 2112791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.